Acadian Asset Management
LUMO

Acadian Asset Management’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Acadian Asset Management’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-2,186
Closed -$22K – 2076
2021
Q2 		$22K Sell
2,186
-3,693
-63% -$41.1K ﹤0.01% 1934
2021
Q1 		$69K Buy
5,879
+2,315
+65% +$38.9K ﹤0.01% 1759
2020
Q4 		$127K Sell
3,564
-1,597
-31% -$27.5K ﹤0.01% 1683
2020
Q3 		$71K Sell
5,161
-30,884
-86% -$462K ﹤0.01% 1762
2020
Q2 		$594K Buy
+36,045
New +$429K ﹤0.01% 1140
2020
Q1 		– Sell
-57,069
Closed -$1.3M – 1965
2019
Q4 		$1.3M Sell
57,069
-5,084
-8% -$72.5K 0.01% 813
2019
Q3 		$889K Buy
62,153
+1,454
+2% +$21.3K ﹤0.01% 922
2019
Q2 		$808K Buy
60,699
+15,801
+35% +$239K ﹤0.01% 859
2019
Q1 		$780K Buy
44,898
+9,175
+26% +$137K ﹤0.01% 978
2018
Q4 		$489K Buy
35,723
+3,602
+11% +$63.4K ﹤0.01% 909
2018
Q3 		$691K Buy
32,121
+3,403
+12% +$103K ﹤0.01% 812
2018
Q2 		$1.23M Buy
+28,718
New +$1.32M 0.01% 683
2018
Q1 		– Sell
-2,163
Closed -$158K – 1869
2017
Q4 		$158K Buy
2,163
+1,530
+242% +$127K ﹤0.01% 1001
2017
Q3 		$58K Buy
+633
New +$48.5K ﹤0.01% 1088
2017
Q1 		– Sell
-2,705
Closed -$250K – 1811
2016
Q4 		$250K Buy
+2,705
New +$305K ﹤0.01% 978
2016
Q2 		– Sell
-73,042
Closed -$12M – 1555
2016
Q1 		$12M Sell
73,042
-17,486
-19% -$3.54M 0.06% 254
2015
Q4 		$29.6M Buy
90,528
+28,313
+46% +$9.22M 0.15% 163
2015
Q3 		$20.1M Buy
62,215
+18,814
+43% +$8.27M 0.11% 194
2015
Q2 		$17.3M Buy
+43,401
New +$18.4M 0.08% 212

Other funds holding LUMO

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
LPC
Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Acadian Asset Management's LUMO Position: Q3 2021 in Review

Acadian Asset Management sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q3 2021, closing a stake of 2,186 shares — an estimated $22K sold.

Acadian Asset Management first reported a position in LUMO in Q2 2015 and held it in 19 quarters. The position peaked at $29.6M in Q4 2015. 37 funds tracked by Wall St. Rank hold LUMO as of Q3 2021.

  • Acadian Asset Management reported no remaining Lumos Pharma, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Acadian Asset Management sold 2,186 Lumos Pharma, Inc. Common Stock shares in Q3 2021, an estimated $22K.
  • Acadian Asset Management first reported a position in Lumos Pharma, Inc. Common Stock in Q2 2015 and held it in 19 quarters.
  • Acadian Asset Management's Lumos Pharma, Inc. Common Stock position peaked at $29.6M in Q4 2015.
  • 37 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q3 2021.

Based on Acadian Asset Management's 13F filing for Q3 2021, filed 12 Nov 2021.